Duchenne muscular dystrophy (DMD) is a severe, progressive, and ultimately fatal disease
of skeletal muscle wasting, respiratory insufficiency, and cardiomyopathy. The identification …

Sarcopenia characterized by reduced skeletal muscle mass and decreased muscle strength
is increasing in prevalence globally. The pathophysiology of sarcopenia is related to various …

Muscle weakness and wasting are defining features of cancer-induced cachexia.
Mitochondrial stress occurs before atrophy in certain muscles, but the possibility of …

Mitochondrial stress may be a secondary contributor to muscle weakness in inherited
muscular dystrophies. Duchenne muscular dystrophy has received the majority of attention …

Duchenne muscular dystrophy (DMD) is a devastating disease affecting approximately 1 in
every 3,500 male births worldwide. Multiple mutations in the dystrophin gene have been …

Fibrosis is associated with respiratory and limb muscle atrophy in Duchenne muscular
dystrophy (DMD). Current standard of care partially delays the progression of this myopathy …

Duchenne muscular dystrophy (DMD) is associated with distinct mitochondrial stress
responses. Here, we aimed to determine whether the prospective mitochondrial-enhancing …

Electrophysiological and structural disruptions in cardiac arrhythmias are closely related to
mitochondrial dysfunction. Mitochondria are an organelle generating ATP, thereby satisfying …

Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by
mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of …

Objectives A high proportion of women with advanced epithelial ovarian cancer (EOC)
experience weakness and cachexia. This relationship is associated with increased morbidity …